The relatively recent identification of a subgroup of patients with apparent behavioral variant frontotemporal dementia (bvFTD) that fails to progress with time has led to a reevaluation of our understanding of bvFTD, and a growing body of research that attempts to characterize the mimic or “phenocopy” syndrome. In this article, we review the literature relating to the phenocopy syndrome, focusing in particular on distinguishing characteristics and potential etiologies.
Methods:
Published articles were identified via a systematic search of PubMed and Embase. Observational and interventional studies, case reports, and case series were sought for inclusion.
Results:
While bvFTD and the phenocopy syndrome are clinically indistinguishable at initial presentation, the presence or absence of characteristic changes on neuroimaging predicts 2 very different illness trajectories. The etiology for the phenocopy presentation remains uncertain. It is likely that the syndrome represents a heterogenous assortment of clinical frontal syndromes encompassing atypical neurodegenerative, psychiatric, psychological, and as yet unknown neuropsychiatric causes.
Conclusions:
Although the prognosis of the phenocopy syndrome is generally held to be more favorable than that of bvFTD, patients and families are subject to major disruption in their relationships and social and occupational functioning. Early recognition is crucial to facilitate timely interventions aimed at maintaining relationships, roles, and quality of life of those affected.
MillerBLBoeveBF. The Behavioral Neurology of Dementia. Cambridge University Press; 2009.
2.
MackenzieIRNeumannMBigioEH, et al.Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol. 2009;117(6):15–18.
3.
RiedijkSRDe VugtMEDuivenvoordenHJ, et al.Caregiver burden, health-related quality of life and coping in dementia caregivers: a comparison of frontotemporal dementia and Alzheimer’s disease. Dement Geriat Cognit Disord. 2006;22(1):405–412.
4.
MioshiEBristowMCookRHodgesJR. Factors underlying caregiver stress in frontotemporal dementia and Alzheimer’s disease. Dement Geriat Cognit Disord. 2009;27(6):76–81.
5.
TalericoKAEvansLK. Responding to safety issues in frontotemporal dementias. Neurology. 2001;56(3):S52–S55.
6.
ChowTWBinnsMACummingsJL, et al.Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type. Arch Neurol. 2009;66(9):888–893.
7.
LiljegrenMNaasanGTemlettJ, et al.Criminal behavior in frontotemporal dementia and Alzheimer disease. JAMA neurology. 2015;72(1):295–300.
8.
HodgesJRDaviesRXuerebJKrilJHallidayG. Survival in frontotemporal dementia. Neurology. 2003;61(4):349–354.
9.
GarcinBLilloPHornbergerM, et al.Determinants of survival in behavioral variant frontotemporal dementia. Neurology. 2009;73(7):1656–1661.
10.
RascovskyKSalmonDPLiptonAM, et al.Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005;65(2):397–403.
11.
DaviesRRKippsCMMitchellJKrilJJHallidayGMHodgesJR. Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol. 2006;63(3):1627–1631.
12.
KippsCMNestorPJDawsonCEMitchellJHodgesJR. Measuring progression in frontotemporal dementia: implications for therapeutic interventions. Neurology. 2008;70(2):2046–2052.
13.
NearyDSnowdenJSGustafsonL, et al.Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(5):1546–1554.
14.
KippsCMDaviesRRMitchellJKrilJJHallidayGMHodgesJR. Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale. Dementia Geriat Cognit Disord. 2007;23:334–342.
15.
KippsCMNestorPJFryerTDHodgesJR. Behavioural variant frontotemporal dementia: not all it seems?Neurocase. 2007;13(4):237–247.
16.
HornbergerMPiguetOKippsCHodgesJR. Executive function in progressive and nonprogressive behavioral variant frontotemporal dementia. Neurology. 2008;71(5):1481–1488.
17.
MattssonNRuetschiUPijnenburgYA, et al.Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia. Mole med rep. 2008;1(6):757–761.
18.
HornbergerMShelleyBPKippsCMPiguetOHodgesJR. Can progressive and non-progressive behavioural variant frontotemporal dementia be distinguished at presentation?J Neurol Neurosurg Psych. 2009;80(4):591–593.
19.
KippsCMHodgesJRFryerTDNestorPJ. Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype. Brain. 2009;132(5):2566–2578.
20.
KippsCMNestorPJAcosta-CabroneroJArnoldRHodgesJR. Understanding social dysfunction in the behavioural variant of frontotemporal dementia: the role of emotion and sarcasm processing. Brain. 2009;132(7):592–603.
21.
MioshiEHodgesJR. Rate of change of functional abilities in frontotemporal dementia. Dement Geriatr Cogn Disord. 2009;28(5):419–426.
22.
MioshiEKippsCMHodgesJR. Activities of daily living in behavioral variant frontotemporal dementia: differences in caregiver and performance-based assessments. Alzheimer Disease Associat Disord. 2009;23(1):70–76.
23.
HornbergerMPiguetOGrahamAJNestorPJHodgesJR. How preserved is episodic memory in behavioral variant frontotemporal dementia?Neurology. 2010;74(3):472–479.
24.
PolettiMBorelliPBonuccelliU. The neuropsychological correlates of pathological lying: evidence from behavioral variant frontotemporal dementia. J Neurol. 2011;258(2):2009–2013.
25.
PenningtonCHodgesJRHornbergerM. Neural correlates of episodic memory in behavioral variant frontotemporal dementia. JAD. 2011;24(1):261–268.
26.
RascovskyKHodgesJRKnopmanD, et al.Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(4):2456–2477.
27.
IrishMGrahamAGrahamKSHodgesJRHornbergerM. Differential impairment of source memory in progressive versus non-progressive behavioral variant frontotemporal dementia. Arch Clin Neuropsychol. 2012;27(3):338–347.
28.
KhanBKYokoyamaJSTakadaLT, et al.Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatry. 2012;83(4):358–364.
29.
BrodtmannACowieTMc LeanCDarbyD. Phenocopy or variant: a longitudinal study of very slowly progressive frontotemporal dementia. BMJ Case Rep. 2013:2013.
30.
BertouxMde SouzaLCCorlierF, et al.Two distinct amnesic profiles in behavioral variant frontotemporal dementia. Biol Psychiat. 2014;75(5):582–588.
KerklaanBJvan BerckelBNHerholzK, et al.The added value of 18-fluorodeoxyglucose-positron emission tomography in the diagnosis of the behavioral variant of frontotemporal dementia. Am J Alzheimers Dis Other Demen. 2014;29(7):607–613.
33.
KumforFIrishMLeytonC, et al.Tracking the progression of social cognition in neurodegenerative disorders. J Neurol Neurosurg Psych. 2014;85(2):1076–1083.
34.
LeeSEKhazenzonAMTrujilloAJ, et al.Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. Brain. 2014;137(8):3047–3060.
35.
DevenneyEBartleyLHoonC, et al.Progression in behavioral variant frontotemporal dementia: a longitudinal study. JAMA Neurol. 2015;72(6):1501–1509.
36.
SuhonenNMKaivorinneALMoilanenV, et al.Slowly progressive frontotemporal lobar degeneration caused by the C9ORF72 repeat expansion: a 20-year follow-up study. Neurocase. 2015;21(6):85–89.
37.
DevenneyEForrestSLXuerebJKrilJJHodgesJR. The bvFTD phenocopy syndrome: a clinicopathological report. J Neurol Neurosurg Psych. 2016;87(4):1155–1156.
38.
DolsAKrudopWMollerCShulmanKSajatovicMPijnenburgYA. Late life bipolar disorder evolving into frontotemporal dementia mimic. Neuropsych Disease Treat. 2016;12(3):2207–2212.
39.
GossinkFTDolsAKerssensCJ, et al.Psychiatric diagnoses underlying the phenocopy syndrome of behavioural variant frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2016;87(1):64–68.
40.
SteketeeRMMeijboomRBronEE, et al.Structural and functional brain abnormalities place phenocopy frontotemporal dementia (FTD) in the FTD spectrum. Neuroimage Clin. 2016;11(2):595–605.
41.
WoodRMoodleyKHodgesJRAllinsonKSpillantiniMGChanD. Slowly progressive behavioural presentation in two UK cases with the R406 W MAPT mutation. Neuropathol Appli Neurobiol. 2016;42(3):291–295.
42.
MeijboomRSteketeeRMde KoningI, et al.Functional connectivity and microstructural white matter changes in phenocopy frontotemporal dementia. Euro Radiol. 2017;27(12):1352–1360.
43.
DevenneyESwinnTMioshiE, et al.The behavioural variant frontotemporal dementia phenocopy syndrome is a distinct entity – evidence from a longitudinal study. BMC Neurol. 2018;18(3):56.
44.
Llamas-VelascoSGarcia-RedondoAHerrero-San MartinA, et al.Slowly progressive behavioral frontotemporal dementia with C9orf72 mutation. Case report and review of the literature. Neurocase. 2018; 24:68–71.
45.
BusseCPettenuzzoIPompaninS, et al.Psychiatric phenocopy syndrome of behavioral frontotemporal dementia: behavioral and cognitive fingerprint. JAD. 2019;72(1):1159–1164.
46.
GossinkFTVijverbergEKrudopW, et al.Predicting progression in the late onset frontal lobe syndrome. Int Psychogeriat. 2019;31(5):743–748.
47.
MeijboomRSteketeeRMEJiskootLC, et al.Qualitative assessment of longitudinal changes in phenocopy frontotemporal dementia. Front Neurol. 2019;10(4):1207.
48.
SellamiLSt-OngeFPoulinSLaforceRJr. Schizophrenia phenotype preceding behavioral variant frontotemporal dementia related to C9orf72 repeat expansion. Cogn Behav Neurol. 2019;32(2):120–123.
49.
McDonaldSFlanaganSRollinsJKinchJ.TASIT: a new clinical tool for assessing social perception after traumatic brain injury. J Head Trauma Rehabil. 2003;18(3):219–238.
50.
Diehl-SchmidJGrimmerTDrzezgaA, et al.Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Agin. 2007;28(1):42–50.
51.
KerteszAMcMonaglePBlairMDavidsonWMunozDG. The evolution and pathology of frontotemporal dementia. Brain. 2005;128(Pt 9):1996–2005.
52.
DeJesus-HernandezMMackenzieIRBoeveBF, et al.Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(3):245–256.
53.
RentonAEMajounieEWaiteA, et al.A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257–268.
